SCHEMBL15079368

SCHEMBL15079368

CCc1ccc(OCCc2ccccc2O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.47
CYP4A11 Q02928 1/20 0.47
KDM4E B2RXH2 2/20 0.46
LMNA P02545 3/20 0.45
MAPT P10636 4/20 0.44
HPGD P15428 2/20 0.44
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
TYR P14679 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
FFAR1 O14842 1/20 0.43
HTR1A P08908 1/20 0.42
ATM Q13315 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA7 P36544 1/20 0.41
MPO P05164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15079893 0.89 ALDH1A1 (0.49) CYP4F2CYP4A11LMNAALDH1A1SMN1; SMN2
SCHEMBL15079410 0.87 CYP4F2 (0.49) CYP4F2CYP4A11KDM4ELMNAMAPT
SCHEMBL15079871 0.83 MAPT (0.51) CYP4F2CYP4A11LMNAMAPTHPGD
SCHEMBL15079867 0.83 MEN1 (0.51) CYP4F2CYP4A11MAPTHPGDL3MBTL1
SCHEMBL16368719 0.83 CYP4F2 (0.51) CYP4F2CYP4A11LMNATYRTAAR1
SCHEMBL9854724 0.83 KCNA3 (0.52) CYP4F2CYP4A11ALDH1A1TYRTAAR1
SCHEMBL9854722 0.81 MPO (0.51) CYP4F2CYP4A11LMNAMAPTL3MBTL1
SCHEMBL15079415 0.81 LMNA (0.61) LMNAMAPTSMN1; SMN2L3MBTL1FFAR1
SCHEMBL15079379 0.80 RAB9A (0.59) CYP4F2CYP4A11LMNAMAPTALDH1A1
SCHEMBL15079855 0.80 CYP4F2 (0.49) CYP4F2CYP4A11SMN1; SMN2L3MBTL1TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2015-01-01 US disclosed
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2015-01-01 US disclosed
WO-2013093320-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS ARG1, TYR, NOS1 CYP4F2 2430/4885CYP4A11 2076/4885KDM4E 598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.